Increasing awareness, participation, funding and streamlining communication for MS trials.
22nd January, 2015
Participate in a survey to understand attitudes, emotions and wellbeing in individuals with MS
4th December, 2014
Pharmaceutical company, Novartis, has released disappointing news that Gilenya does not slow disability in a clinical trial for primary progressive MS